University of California San Francisco
Give to UCSFGal-3C, a galectin-3 inhibitor, shows promise in limiting post-MI scarring, improving cardiac function, and outperforming current therapies.
Study finds DOACs may lower recurrent VTE risk over warfarin in extended treatment. Observational evidence supports DOAC use.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
Adverse experiences early in childhood and early life have been linked to lifelong health consequences.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Improving predictive models with artificial intelligence may help advance diagnostics for heart disease and limit invasive testing with catheters that can be risky, especially for patients already experiencing heart and stroke issues.
UCSF is one of four U.S. hospitals to be verified as part of the ACS Vascular Verification Program.
UCSF primary care physician and researcher Alka M. Kanaya, MD, is being recognized with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.
A new study shows that percutaneous coronary intervention can improve patient outcomes in communities with unmet needs.
While some patients recover from the effects of COVID-19, others experience the aftereffects long after the initial infection. UC San Francisco researchers are studying why some COVID-19 patients
Deep neural networks (DNNs) can be used to collect data that predicts cardiac pump function.
A study found that intensive blood pressure control is associated with lower risk of left ventricular conduction disease, indicating left ventricular conduction disease may be preventable.
A hepatitis outbreak in children occurred after COVID-19 lockdowns eased in 2022. Sudden exposure to a multitude of viruses upon reopening may have triggered this response in a small group of children.
Pregnant women have a lower risk of gestational diabetes and unhealthy weight gain in cities that tax sugary drinks, according to a first-of-its-kind study of more than 5 million women by UCSF.
What is “social prescribing” and what is UCSF doing to promote it? UCSF experts address the health ramifications of social isolation.
A higher-calorie nutrition plan isn’t more distressing for hospitalized teens and young adults with anorexia than a lower-calorie plan.
UCSF’s Jason Nagata advises that ingraining healthy screen habits in kids as early as possible can help decrease chances of suicidal behavior.
Oakland Promise’s Brilliant Baby program seeds $500 college funds for Medi-Cal-eligible babies, provides families with free financial coaching, and offers educational programming for caregivers.
UCSF experts share insights and tips on supporting children with ADHD amidst a shortage of Adderall and other ADHD medications.
Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.
A UCSF study finds increase in percutaneous coronary intervention (PCI) at low-volume hospitals over time for all races, insurance types and incomes.
In a Q&A, UCSF’s Jason Nagata answers questions about the links between screen time and illnesses like OCD for children and teens.